These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study. Ta D, Ishaque A, Srivastava O, Hanstock C, Seres P, Eurich DT, Luk C, Briemberg H, Frayne R, Genge AL, Graham SJ, Korngut L, Zinman L, Kalra S. Neurology; 2021 Aug 24; 97(8):e803-e813. PubMed ID: 34426551 [Abstract] [Full Text] [Related]
6. Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy. Weerasekera A, Peeters R, Sima D, Dresselaers T, Sunaert S, De Vocht J, Claeys K, Van Huffel S, Van Damme P, Himmelreich U. Brain Res; 2019 Sep 01; 1718():22-31. PubMed ID: 31002818 [Abstract] [Full Text] [Related]
9. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. Foerster BR, Pomper MG, Callaghan BC, Petrou M, Edden RA, Mohamed MA, Welsh RC, Carlos RC, Barker PB, Feldman EL. JAMA Neurol; 2013 Aug 01; 70(8):1009-16. PubMed ID: 23797905 [Abstract] [Full Text] [Related]
11. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. Pohl C, Block W, Träber F, Schmidt S, Pels H, Grothe C, Schild HH, Klockgether T. J Neurol Sci; 2001 Sep 15; 190(1-2):21-7. PubMed ID: 11574102 [Abstract] [Full Text] [Related]
13. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Kalra S, Hanstock CC, Martin WR, Allen PS, Johnston WS. Arch Neurol; 2006 Aug 15; 63(8):1144-8. PubMed ID: 16908742 [Abstract] [Full Text] [Related]
14. Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. Unrath A, Ludolph AC, Kassubek J. J Neurol; 2007 Aug 15; 254(8):1099-106. PubMed ID: 17431700 [Abstract] [Full Text] [Related]
15. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Neurology; 1998 Jun 15; 50(6):1800-5. PubMed ID: 9633731 [Abstract] [Full Text] [Related]
16. The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis. Sako W, Abe T, Izumi Y, Harada M, Kaji R. J Clin Neurosci; 2016 May 15; 27():110-3. PubMed ID: 26765768 [Abstract] [Full Text] [Related]
17. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Suhy J, Miller RG, Rule R, Schuff N, Licht J, Dronsky V, Gelinas D, Maudsley AA, Weiner MW. Neurology; 2002 Mar 12; 58(5):773-9. PubMed ID: 11889242 [Abstract] [Full Text] [Related]
18. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. Han J, Ma L. J Magn Reson Imaging; 2010 Feb 12; 31(2):305-8. PubMed ID: 20099342 [Abstract] [Full Text] [Related]
19. Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis. Ratai EM, Alshikho MJ, Zürcher NR, Loggia ML, Cebulla CL, Cernasov P, Reynolds B, Fish J, Seth R, Babu S, Paganoni S, Hooker JM, Atassi N. Neuroimage Clin; 2018 Feb 12; 20():357-364. PubMed ID: 30112276 [Abstract] [Full Text] [Related]
20. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Wang S, Poptani H, Woo JH, Desiderio LM, Elman LB, McCluskey LF, Krejza J, Melhem ER. Radiology; 2006 Jun 12; 239(3):831-8. PubMed ID: 16641339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]